Main Session
Sep
27
PQA 02 - PQA 02: Pediatric Cancer, Sarcoma and Cutaneous Tumors, Medical Education & Professional Development, and Health Services Research
2329 - A Phase III Study of 131I-Metaiodobenzylguanidine (131I-MIBG) or Lorlatinib Added to Intensive Therapy for Children with Newly Diagnosed High-Risk Neuroblastoma (ANBL1531)
Presenter(s)
Christine Hill-Kayser, MD - University of Pennsylvania, Philadelphia, PA